What's Trending

A major Federal Circuit ruling just sent a clear message to AI-driven healthtech companies: AI alone won’t get you a patent. In AliveCor,...

On February 28, 2025, the United States Patent and Trademark Office (USPTO) rescinded a June 2022 memorandum clarifying when the Patent...

The U.S. Patent and Trademark Office (USPTO) faces unique challenges amid discussions on altering telework policies. With 96% of its...

The U.S. Patent and Trademark Office (USPTO) has implemented three new rules impacting practice before the Patent Trial and Appeal Board...

U.S. Patent and Trademark Office Director Kathi Vidal announced her departure from the agency to return to the private sector, a move...

The U.S. Patent and Trademark Office director, Kathi Vidal, released a final rule on Director Review effective October 31, which expands...

The United States Patent and Trademark Office (USPTO) has announced new rules governing amendment practice in trial proceedings under the...

The recent case involving United Therapeutics' patent on Tyvaso and Liquidia's Yutrepia sheds light on the complexities of patent law....

Recent cases show the U.S. Patent and Trademark Office director's interest in using director review to address substantive issues like...

The Court of Appeals for the Federal Circuit has sparked debate following a recent ruling on the Patent Trial and Appeal Board's (PTAB)...

United States Patent and Trademark Office Director Kathi Vidal's recent sanctions decisions have been notable for their seriousness and...

The U.S. Supreme Court's decision to no longer give deference to government agency interpretations could lead to challenges against U.S....